Abnormal kidney function as a cause and a consequence of obesity hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 1, 1998, Pages 58-64

  Hall, John E ^a   Brands, Michael W ^a   Henegar, Jeffrey R ^a   Shek, Eugene W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Kidney; Obesity; Renin angiotensin system; Sodium excretion; Sympathetic nervous system

Indexed keywords

SODIUM;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY TUBULE ABSORPTION; NATRIURESIS; NUTRITIONAL DISORDER; OBESITY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPINAL CORD COMPRESSION;

EID: 0031906524     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02146.x     Document Type: Conference Paper

References (53)

1. Najjar M, Rowland M for the National Center for Health Statistics. Anthropometric reference data and prevalence of overweight: United States, 1976-80. Washington, DC; Government Printing Office. 1987; Department of Health and Human Services Publication No. (PHS) 87-1688.
2. Stamler J. Epidemic obesity in the United States. Arch. Intern. Med. 1993; 153: 1040-4.
3. Hall JE, Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381-94.
4. Ribstein J, du Cailar J, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610-15.
5. Chiang BW, Perlman LV, Epstein FH. Overweight and hypertension: A review. Circulation 1969; 39: 403-21.
6. Alexander J, Dustan HP, Sims EAH, Tarazi R. Report of the Hypertension Task Force, Vol. Washington DC: US Government Printing Office. 1979; US Department of Health, Education, and Welfare Publication 70-1631 (NIH).
7. Kumanyika S. Obesity in black women. Epidemiol. Rev. 1987; 9: 31-50.
8. Jones DW, Kim JS, Andrew ME, Kim SH, Hon YP. Body mass index and blood pressures in Korean men and women: The Korean National Blood Pressure Survey. J. Hypertens. 1994; 12: 1433-7.
9. Reisen E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 1978; 198: 1-6.
10. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M. Weight and hypertension. Ann. Intern. Med. 1983; 98: 855-9.
11. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension: Renal function and systemic hemodynamics. Hypertension 1993; 22: 292-9.
12. Rocchini AP. Cardiovascular changes in obesity-induced hypertension. Hypertension 1992; 19 (Suppl. I): I-56-60.
13. Guyton AC. The surprising kidney-fluid mechanism for pressure control: Its infinite gain! Hypertension 1990; 16: 725-30.
14. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension 1990; 15: 547-59.
15. Rocchini AP, Key J, Bordie D et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N. Engl. J. Med. 1989; 321: 580-5.
16. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am. J. Hypertens. 1997; 10: S49-55.
17. Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992; 19 (Suppl. I): I-67-77.
18. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am. J. Hypertens. 1989; 2: 1255-325.
19. Reaven GM, Hoffman BB. A role for insulin in the aetiology and course of hypertension. Lancet 1987; 2: 435-7.
20. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats: Role of angiotension II. Hypertension 1996; 28: 1047-54.
21. Tuck ML, Sowers J, Dornfield L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N. Engl. J. Med. 1981; 304: 930-3.
22. Hall JE, Zappe DH, Alonso-Galicia M, Granger JP, Brands MW, Kassab SE. Mechanisms of obesity-induced hypertension. News Physiol. Sci. 1996; 11: 255-61.
23. Carroll JF, Dwyer TM. Brady AW et al. Hypertension cardiac hypertrophy and neurohumoral activity in a new animal model of obesity. Am. J. Physiol. 1996; 271: H373-8.
24. Reisin E, Messerli FH, Ventura HO, Frohlich ED. Renal hemodynamics in obese and lean essential hypertensive patients. In: Meserli FH (ed.). Kidney in Essential Hypertension. Boston, Martinus Nihoff. 1948; 125-9.
25. Hall JE. Hyperinsulinemia: A link between obesity and hypertension? Kidney Int. 1993; 43: 1402-17.
26. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure. Hypertension 1985; 7: 702-6.
27. Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Cardiovascular actions of insulin: Are they important in long-term blood pressure regulation? Clin. Exp. Pharmacol. Physiol. 1995; 22: 689-700.
28. Hall JE, Summers RL, Brands MW, Keen H, Alonso-Galicia M. Resistance to metabolic actions of insulin and its role in hypertension. Am. J. Hypertens. 1994; 7: 772-88.
29. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992; 19: 621-7.
30. Hall JE, Brands MW, Zappe DH et al. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin resistant dogs. Hypertension 1995; 25: 994-1002.
31. Brands MW, Hildebrandt CA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am. J. Physiol. 1991; 260: R764-8.
32. Dubey R, Zhang HY, Reddy SR, Boegehold MA, Kotchen TA. Pioglitazone attenuates hypertension and inhibits growth of renal arterial smooth muscle in rats. Am. J. Physiol. 1993; R726-32.
33. Zhang F, Sowers JR, Ram JL, Peuler JD. Effects of pioglitazone or calcium channels in vascular smooth muscle. Hypertension 1994; 24: 170-5.
34. Hall JE, Henegar JR, Shek EW, Brands MW. Role of renin-angiotensin system in obesity hypertension. Circulation 1998 (in press).
35. Robles RG, Villa E, Santirso R et al. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am. J. Hypertens. 1993; 6: 1009-19.
36. Jones PP, Davy KP, Alexander S, Seals DR. Age related increase in muscle sympathetic nerve activity is associated with abdominal obesity. Am. J. Physiol. 1997; 272: E976-80.
37. Grassi G, Servalle G. Cattaneo BM et al. Sympathetic activity in obese normotensive subjects. Hypertension 1995; 25: 560-3.
38. Hall JE, Van Vliet BN, Garrity CA, Torrey C, Brands MW. Obesity hypertension: Role of adrenergic mechanisms. Hypertension 1993; 21: 528 (Abstract).
39. Van Vliet BN, Hall JE, Mizelle HL, Montani J-P, Smith MJ Jr. Reduced parasympathetic control of heart rate in obese dogs. Am. J. Physiol. 1995; 269: H629-37.
40. Aronne LJ, MacKintosh R, Rosenbaum M, Leibel RL, Hirsch J. Autonomic nervous system activity in weight gain and weight loss. Am. J. Physiol. 1995; 269: 222-5.
41. Kassab S, Wilkins C, Kato T, Mizelle HL, Hall JE, Granger JP. Renal nerves play an important role in mediating the sodium retention in response to a high fat diet in conscious dogs. Am. J. Hypertens. 1994; 7: 260 (Abstract).
42. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Bilateral renal denervation prevents the development of obesity-induced hypertension in dogs. Hypertension 1994; 3: 375 (Abstract).
43. Zappe DH, Capel WT, Keen HL et al. Role of renal afferent nerves in obesity-induced hypertension. Am. J. Hypertens. 1996; 9: 20A (Abstract).
44. Hildebrandt DA, Heath BJ, Hall JE. Systemic arterial pressure and heart rate responses to chronic carotid or vertebral artery insulin infusion. FASEB J. 1994; 8: A528 (Abstract).
45. Halaas JL, Gajiwala KS, Maffei M et al. Weight reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
46. Chua SC Jr, Chung WK. Wu-Peng XS et al. Phenotypes of mouse diabetes and fatty rat due to mutation of the ob receptor. Science 1996; 271: 994-6.
47. Haynes WG, Morgan DA, Walsh SA, Mark AL, Swite WI. Leptin increases sympathetic nerve activity in brown adipose tissue and kidney. FASEB J. 1997; 11: A4 (Abstract).
48. Shek EW, Brands MW, Hall JE. Cardiovascular and renal actions of chronic central nervous system leptin infusion. Hypertension 1997; 30: 472 (Abstract).
49. Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner renal medulla of obese dogs. Hypertension 1995; 25: 888-92.
50. Arnold MD, Brissie R, Soonz JS, Dwyer T, Hall J, Herrera GA. Obesity associated renal medullary changes. Lab. Invest. 1994; 70: 156A (Abstract).
51. Wesson DE, Kurtzman NA, Prommer JP. Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron 1985; 40: 235-7.
52. Henegar JR, Shek EW, Henegar L, Hall JE. Renal functional and structural changes in the early stages of obesity. Hypertension 1997; 30: 474 (Abstract).
53. The National Institutes of Health. United States Renal Data System: 1994 Annual Report. Ann Arbor, MI: University of Michigan. 1994.